The SRC only has to review data from 4 patients...they are also only looking at safety (confirmed on many prior trials) and whether there is evidence of anti dengue activity (fairly low threshold, I'd say). this may help with a quick decision.
I'm confident in the safety and efficacy of the drug, thus feeling hopeful.
The SRC only has to review data from 4 patients...they are also...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.020(13.3%) |
Mkt cap ! $42.02M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 17.0¢ | 14.5¢ | $91.38K | 584.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 255000 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 191400 | 5 |
View Market Depth
| Last trade - 15.55pm 30/07/2025 (20 minute delay) ? |
| ILA (ASX) Chart |